Cellular Biomedicine Gr Q3 EPS $(0.82) Misses $(0.67) Estimate

Cellular Biomedicine Gr (NASDAQ:CBMG) reported quarterly losses of $(0.82) per share which missed the analyst consensus estimate of $(0.67) by 22.39 percent. This is a 46.43 percent decrease over losses of $(0.56) per

Benzinga · 11/06/2019 22:23

Cellular Biomedicine Gr (NASDAQ:CBMG) reported quarterly losses of $(0.82) per share which missed the analyst consensus estimate of $(0.67) by 22.39 percent. This is a 46.43 percent decrease over losses of $(0.56) per share from the same period last year.